國美零售(00493.HK)創始人黃光裕正式獲釋 受利好提振昨日股價創2015年5月以來新高
格隆匯2月17日丨國美零售(00493.HK)公吿稱,就有關北京一中院裁定對公司控股股東黃光裕先生的假釋的事宜,假釋考驗期限自假釋之日起至2021年2月16日止。董事會已獲悉,黃先生的假釋考驗期已於2021年2月16日屆滿,原判刑罰已經執行完畢以及黃先生已正式獲釋。
國美零售昨日(16日)跳空高開,股價一路高歌猛進,收盤最終以光頭光腳大陽線報收。全天漲幅達33.93%,收報2.25港元,創2015年5月以來新高,成交額20.25億港元,最新總市值為484.93億港元。國美零售今年以來累計漲幅超140%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.